<!doctype html public "-//w3c//dtd html 4.0 transitional//en">
<html>
<head>
   <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
   <meta name="ProgId" content="FrontPage.Editor.Document">
   <meta name="Generator" content="Microsoft FrontPage 5.0">
   <meta name="Originator" content="Microsoft Word 9">
   <meta name="GENERATOR" content="Mozilla/4.77C-SGI [en] (X11; I; IRIX 6.5 IP32) [Netscape]">
   <title>RACHEL overview</title>
<link rel=Edit-Time-Data href="./RACHEL_overview_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
   </style>
<![endif]-->
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Chris M. W. Ho, M.D.,Ph.D.</o:Author>
  <o:LastAuthor>Chris M. W. Ho, M.D.,Ph.D.</o:LastAuthor>
  <o:Revision>4</o:Revision>
  <o:TotalTime>18</o:TotalTime>
  <o:Created>2002-08-15T04:30:00Z</o:Created>
  <o:LastSaved>2002-08-15T04:50:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>298</o:Words>
  <o:Characters>1703</o:Characters>
  <o:Company>Drug Design Methodologies, LLC.</o:Company>
  <o:Lines>14</o:Lines>
  <o:Paragraphs>3</o:Paragraphs>
  <o:CharactersWithSpaces>2091</o:CharactersWithSpaces>
  <o:Version>9.2720</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
  <o:DoNotRelyOnCSS/>
  <o:PixelsPerInch>120</o:PixelsPerInch>
  <o:TargetScreenSize>1024x768</o:TargetScreenSize>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536902279 -2147483648 8 0 511 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:windowtext; margin-left:0in; margin-right:0in; margin-top:0in}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:windowtext;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{margin-right:0in;
	mso-margin-top-alt:auto;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:black;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
@list l0
	{mso-list-id:588581100;
	mso-list-type:hybrid;
	mso-list-template-ids:-881837582 67698689 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
   </style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1032"/>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>
<body link="#0000FF" vlink="#800080" lang="EN-US" style="tab-interval:.5in" bgcolor="#FFFFFF">

<div class=Section1 style="width: 708; height: 205">&nbsp;
  <table border="1" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#FFFFFF" width="100%" height="143">
    <tr>
      <td width="50%" height="143" align="center" valign="top">
      <p align="center"><a href="Home.html">
      <span style="text-decoration: none">
      <img border="0" src="Home_files/image001.gif" width="225" height="165"></span></a></td>
      <td width="50%" height="143" align="center" bordercolor="#FFFFFF">

<h1>
<font size=+2>RACHEL</font><span style="vertical-align: super; font-weight:400"><sup><font size=1>TM</font></sup></span><font size=+2><span style="font-weight: 400">
</span>stands for:</font></h1>

      <table border="1" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#FFFFFF" width="45%" height="111">
        <tr>
          <td width="100%" height="111">
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">R</font></b>eal-time</font></p>
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">A</font></b>utomated</font></p>
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">C</font></b>ombinatorial</font></p>
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">H</font></b>euristic</font></p>
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">E</font></b>nhancement of</font></p>
          <p style="margin-top: 0; margin-bottom: 0">
<font size=+1><b><font color="#FF0000">L</font></b>ead compounds</font></td>
        </tr>
      </table>
      </td>
    </tr>
  </table>
</div>

<div class="MsoBodyText">
<h4>
She is an all-purpose ligand refinement software package designed to combinatorially
derivatize a lead compound to improve ligand-receptor binding and accelerate
drug discovery.</h4>
</div>

<div class="MsoNormal">
<h4 style="margin-top: 0; margin-bottom: 0">
RACHEL encompasses <a href="Technology.html">
numerous features</a> designed
to work cohesively in this endeavor.</h4>
<p style="margin-top: 0; margin-bottom: 0">
&nbsp;</div>

<ul style='margin-top:0in' type=disc>
<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman">RACHEL
- combinatorial derivatization of user-specified sites to enhance lead
refinement.</font></span></li>

<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman"><a href="Rachel_Theory.htm#Extraction">
<span style="text-decoration: none">Component
database generation, registration, and management.</span></a></font></span></li>

<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman"><a href="Rachel_Theory.htm#AutoSF">
<span style="text-decoration: none">Automated
generation of scoring functions based on user supplied ligand and receptor
data.</span></a></font></span></li>

<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman">Advanced
conformational search engine capable of sampling nearly 1x10<sup>6</sup>
conformers per second.</font></span></li>

<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman"><a href="Rachel_Theory.htm#Language">
<span style="text-decoration: none">User
defined Markush-like building descriptors to direct the generation of structures.</span></a></font></span></li>

<li class="MsoNormal" style="mso-list:l0 level1 lfo3;tab-stops:list .5in">
<span style='font-size:12.0pt'><font size=+0 face="Times New Roman"><a href="Rachel_Theory.htm#ICSS">
<span style="text-decoration: none">Heuristic
component selection and diversity metrics to accelerate the generation
of solutions while ensuring maximum component diversity.</span></a></font></span></li>
</ul>

<div class="MsoNormal" style="text-align:justify">&nbsp;</div>

<center>
<img SRC="RACHEL_overview_files/image003.gif" BORDER=0 v:shapes="_x0000_i1027" align="middle" width="432" height="227"></center>


<p class="MsoNormal" style="text-align:justify"><font size=+0 face="Times">Here
we see an example of RACHEL's implementation.&nbsp; This lead compound
contains a stable, tight-binding region (black), and a phenyl ring that
should be replaced to improve receptor complementarity&nbsp; <font color="#FF0000">(red)</font>.&nbsp;
RACHEL requires the attachment point of the weak-binding portion as input.&nbsp;
She then removes the offending ligand region and uses the attachment point
to create a population of derivatives by adding, deleting, and substituting
fragments chosen from the component database&nbsp; <font color="#008000">(green)
</font>to fill the active site.&nbsp; The binding energies of the resulting
derivative ligands are then calculated.&nbsp; Those structures that augment
binding are retained while those that do not are discarded.&nbsp; This
process repeats as the new population of structures is then processed to
generate the next round of derivatives. By making incremental changes iteratively,
these programs generate a set of ligands with improved receptor complementarity
over time.&nbsp; As stated above, RACHEL possesses <a href="Technology.html">
<span style="text-decoration: none">numerous
features</span></a> that truly separate her from any other <a href="Rachel_Theory.htm#Software">
<span style="text-decoration: none">ligand
design software.</span></a></font><br>
&nbsp;<p class="MsoNormal" style="text-align:center">
<font size="4" color="#FF0000">
<a href="http://www.newdrugdesign.com/RACHEL_Examples.html">
<font color="#FF0000"><span style="text-decoration: none">To see 
real-world examples of RACHEL's utility, please click here.</span></font></a></font><p class="MsoNormal" style="text-align:justify">&nbsp;<p class="MsoNormal" style="text-align: center">(c) 2003 Drug Design 
Methodologies, LLC.&nbsp; All Rights Reserved</p>

</body></html>